Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Evgen Pharma RNS Release

Notification of Major Interest in Shares


RNS Number : 0925B
Evgen Pharma PLC
05 January 2018
 


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Evgen Pharma plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):

change in percentage of voting rights arising upon a new issue of shares by the issuer

ü

3. Full name of person(s) subject to the
notification obligation:

Enterprise Ventures Limited

4. Full name of shareholder(s)
 (if different from 3.):

RisingStars Growth Fund II LP

5. Date of the transaction and date on
which the threshold is crossed or
reached:

Total Voting Rights announcement of the issuer dated 2nd January 2018

6. Date on which issuer notified:

4th January 2017

7. Threshold(s) that is/are crossed or
reached:

13%



 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

GB00BSVYN304

11,950,869

11,950,869

11,950,869

11,950,869

Nil

12.81

Nil


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

None






C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

None




 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

11,950,869

12.81%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



14. Contact name:

Enterprise Ventures Limited

15. Contact telephone number:

  01772 270 570

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGCGDBLSGBGIU

Evgen Pharma Timeline

Article
October 21 2015

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use